Search results with tag "Sculptra"
Billing and Coding Guidelines for Cosmetic and ...
downloads.cms.govQ2028 Sculptra injection Injection, Sculptra, 0.5mg . Regulation Excerpts: CMS Pub. 100-04 Medicare Claims Processing Manual, Chapter 32 - Billing Requirements for Special Services, Sections: 260.2.1 – Hospital Billing Instructions (Rev. 2998, Issued: 07-25-14, Effective: Upon implementation of ICD-10; 01-01-12 - ASC
2020 Plastic Surgery Statistics Report
www.plasticsurgery.orgPolylactic acid (Sculptra™) 134,123165,064* -19% * Polymethyl-methacrylate microspheres (Bellafill) 70,98981,992* -13%* TOTAL COSMETIC MINIMALLY-INVASIVE PROCEDURES 13,281,235 15,750,363 4,847,561 -16% 174% COSMETIC MINIMALLY-INVASIVE PROCEDURES TOTAL COSMETIC PROCEDURES 15,595,955 18,428,665 6,748,610 -15% …
Sculptra (poly-L-lactic acid) - Sanofi
products.sanofi.caSCULPTRA® poly-L-lactic acid DEVICE DESCRIPTION SCULPTRA is an injectable implant that contains microparticles of poly-L-lactic acid, a biocompatible, biodegradable, synthetic polymer from the alpha-hydroxy-acid family. SCULPTRA is reconstituted prior to use by the addition of Sterile Water for Injection (SWFI),
SCULPTRA® Aesthetic (injectable poly-L-lactic acid) Caution
www.galderma.comSCULPTRA Aesthetic is an injectable implant containing microparticles of poly-L-lactic acid (PLLA), carboxymethylcellulose (USP), non-pyrogenic mannitol (USP) and sterile water for injection (USP). SCULPTRA Aesthetic is available in 367.5 mg dose vials and is to be
Sculptra (poly-L-lactic acid) - Sanofi
products.sanofi.caApplication number: 200845 Page 1 of 7 Date of revision: September 17, 2012 s-a Version 2.3 dated September 19, 2012 Instruction Leaflet SCULPTRA® poly-L-lactic acid